Leonardo Brunetti

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Alessio Cortellini, Antonio D’Alessio, Siobhan Cleary et al. · Clinical Cancer Research · 2023 · 74 citations · Full text

Medicine, Immunology, Oncology +16

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi et al. · Journal of Hepatology · 2023 · 63 citations · Full text

Medicine, Immunology, Oncology +17

Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer

Abdul Rafeh Naqash, Justin McCallen, Emma Mi et al. · Journal for ImmunoTherapy of Cancer · 2023 · 55 citations · Full text

Life Sciences, Immunology, Oncology +14

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio et al. · Journal for ImmunoTherapy of Cancer · 2025 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17